Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W F Lems

Showing results (51-60 of 175) with videos related to

Pageof 18
Sort By:
Annals of the Rheumatic Diseases|February 7, 2002
Severe aortic regurgitation in RF positive polyarticular JIAI E M Bultink, W F Lems, B A C Dijkmans, et al.
Osteoarthritis and Cartilage|February 24, 2010
Serum and urinary biochemical markers for knee and hip-osteoarthritis: a systematic review applying the consensus BIPED criteriaW E van Spil, J DeGroot, W F Lems, et al.
Scandinavian Journal of Rheumatology|July 18, 2000
Osteoporosis in patients with rheumatoid arthritis: tip of the iceberg?M C Lodder, S M Bakker, B A Dijkmans, et al.
British Journal of Rheumatology|September 1, 1993
Transient decrease in osteocalcin and markers of type 1 collagen turnover during high-dose corticosteroid pulse therapy in rheumatoid arthritisW F Lems, J W Jacobs, H R van den Brink, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 13, 2004
Prevention and treatment of glucocorticoid-induced osteoporosis with active vitamin D3 analogues: a review with meta-analysis of randomized controlled trials including organ transplantation studiesR N J de Nijs, J W G Jacobs, A Algra, et al.
Annals of the Rheumatic Diseases|November 1, 1993
Effect of hormone replacement therapy on markers of bone metabolism in RAW F Lems, H R van den Brink, M I Gerrits, et al.
Clinical Rheumatology|July 31, 2007
A 57-year-old man who developed arthritis during R-CHOP chemotherapy for non-Hodgkin lymphomaF H Swaneveld, R M van Vugt, J P de Boer, et al.
Lupus|October 23, 2014
Unexpected severe incident vertebral fractures in patients with systemic lupus erythematosus: comment on the article by Zhu et alJ Jacobs, M W P Tsang A Sjoe, A E Voskuyl, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 18, 2016
Effect of twelve-month physical exercise program on patients with osteoporotic vertebral fractures: a randomized, controlled trialL Evstigneeva, O Lesnyak, I E M Bultink, et al.
Clinical and Experimental Rheumatology|March 31, 2009
The proteasome inhibitor bortezomib inhibits the release of NFkappaB-inducible cytokines and induces apoptosis of activated T cells from rheumatoid arthritis patientsJ W van der Heijden, R Oerlemans, W F Lems, et al.
Pageof 18

Showing results (51-60 of 175) with videos related to

Sort By:
Pageof 18
Annals of the Rheumatic Diseases|February 7, 2002
Severe aortic regurgitation in RF positive polyarticular JIAI E M Bultink, W F Lems, B A C Dijkmans, et al.
Osteoarthritis and Cartilage|February 24, 2010
Serum and urinary biochemical markers for knee and hip-osteoarthritis: a systematic review applying the consensus BIPED criteriaW E van Spil, J DeGroot, W F Lems, et al.
Scandinavian Journal of Rheumatology|July 18, 2000
Osteoporosis in patients with rheumatoid arthritis: tip of the iceberg?M C Lodder, S M Bakker, B A Dijkmans, et al.
British Journal of Rheumatology|September 1, 1993
Transient decrease in osteocalcin and markers of type 1 collagen turnover during high-dose corticosteroid pulse therapy in rheumatoid arthritisW F Lems, J W Jacobs, H R van den Brink, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 13, 2004
Prevention and treatment of glucocorticoid-induced osteoporosis with active vitamin D3 analogues: a review with meta-analysis of randomized controlled trials including organ transplantation studiesR N J de Nijs, J W G Jacobs, A Algra, et al.
Annals of the Rheumatic Diseases|November 1, 1993
Effect of hormone replacement therapy on markers of bone metabolism in RAW F Lems, H R van den Brink, M I Gerrits, et al.
Clinical Rheumatology|July 31, 2007
A 57-year-old man who developed arthritis during R-CHOP chemotherapy for non-Hodgkin lymphomaF H Swaneveld, R M van Vugt, J P de Boer, et al.
Lupus|October 23, 2014
Unexpected severe incident vertebral fractures in patients with systemic lupus erythematosus: comment on the article by Zhu et alJ Jacobs, M W P Tsang A Sjoe, A E Voskuyl, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 18, 2016
Effect of twelve-month physical exercise program on patients with osteoporotic vertebral fractures: a randomized, controlled trialL Evstigneeva, O Lesnyak, I E M Bultink, et al.
Clinical and Experimental Rheumatology|March 31, 2009
The proteasome inhibitor bortezomib inhibits the release of NFkappaB-inducible cytokines and induces apoptosis of activated T cells from rheumatoid arthritis patientsJ W van der Heijden, R Oerlemans, W F Lems, et al.
Pageof 18